Filice Federica, Janickova Lucia, Henzi Thomas, Bilella Alessandro, Schwaller Beat
Section of Medicine, Anatomy, University of Fribourg, Fribourg, Switzerland.
Front Cell Neurosci. 2020 Dec 18;14:577525. doi: 10.3389/fncel.2020.577525. eCollection 2020.
The prevalence of autism spectrum disorder (ASD)-a type of neurodevelopmental disorder-is increasing and is around 2% in North America, Asia, and Europe. Besides the known genetic link, environmental, epigenetic, and metabolic factors have been implicated in ASD etiology. Although highly heterogeneous at the behavioral level, ASD comprises a set of core symptoms including impaired communication and social interaction skills as well as stereotyped and repetitive behaviors. This has led to the suggestion that a large part of the ASD phenotype is caused by changes in a few and common set of signaling pathways, the identification of which is a fundamental aim of autism research. Using advanced bioinformatics tools and the abundantly available genetic data, it is possible to classify the large number of ASD-associated genes according to cellular function and pathways. Cellular processes known to be impaired in ASD include gene regulation, synaptic transmission affecting the excitation/inhibition balance, neuronal Ca signaling, development of short-/long-range connectivity (circuits and networks), and mitochondrial function. Such alterations often occur during early postnatal neurodevelopment. Among the neurons most affected in ASD as well as in schizophrenia are those expressing the Ca-binding protein parvalbumin (PV). These mainly inhibitory interneurons present in many different brain regions in humans and rodents are characterized by rapid, non-adaptive firing and have a high energy requirement. PV expression is often reduced at both messenger RNA (mRNA) and protein levels in human ASD brain samples and mouse ASD (and schizophrenia) models. Although the human gene is not a high-ranking susceptibility/risk gene for either disorder and is currently only listed in the SFARI Gene Archive, we propose and present supporting evidence for the Parvalbumin Hypothesis, which posits that decreased PV level is causally related to the etiology of ASD (and possibly schizophrenia).
自闭症谱系障碍(ASD)是一种神经发育障碍,其患病率正在上升,在北美、亚洲和欧洲约为2%。除了已知的遗传联系外,环境、表观遗传和代谢因素也与ASD病因有关。尽管ASD在行为水平上具有高度异质性,但它包含一组核心症状,包括沟通和社交互动技能受损以及刻板和重复行为。这导致有人提出,ASD表型的很大一部分是由少数常见信号通路的变化引起的,识别这些信号通路是自闭症研究的一个基本目标。利用先进的生物信息学工具和大量可用的遗传数据,可以根据细胞功能和信号通路对大量与ASD相关的基因进行分类。已知在ASD中受损的细胞过程包括基因调控、影响兴奋/抑制平衡的突触传递、神经元钙信号传导、短/长距离连接(回路和网络)的发育以及线粒体功能。这些改变通常发生在出生后早期神经发育过程中。在ASD以及精神分裂症中受影响最严重的神经元中,有那些表达钙结合蛋白小白蛋白(PV)的神经元。这些主要是抑制性中间神经元,存在于人类和啮齿动物的许多不同脑区,其特征是快速、非适应性放电,并且能量需求高。在人类ASD脑样本和小鼠ASD(以及精神分裂症)模型中,PV表达在信使核糖核酸(mRNA)和蛋白质水平上通常都会降低。尽管人类基因不是这两种疾病的高排名易感/风险基因,目前仅列在SFARI基因档案中,但我们提出并提供支持证据以支持小白蛋白假说,该假说认为PV水平降低与ASD(可能还有精神分裂症)的病因有因果关系。